Metropolis Healthcare Limited

NSEI:METROPOLIS Rapporto sulle azioni

Cap. di mercato: ₹105.7b

Metropolis Healthcare Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Surendran Chemmenkotil

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO1.8yrs
Proprietà del CEOn/a
Durata media del managementless than a year
Durata media del Consiglio di amministrazione5.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 13
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 14
Metropolis Healthcare Limited (NSE:METROPOLIS) Just Reported And Analysts Have Been Lifting Their Price Targets

Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

May 24
Metropolis Healthcare Limited Just Missed EPS By 5.7%: Here's What Analysts Think Will Happen Next

Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Mar 28
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E

Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Jan 13
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal

Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Dec 23
Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion

Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Sep 08
Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?

Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Jun 20
Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital

Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively

Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Feb 13
Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00

Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Sep 25
Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price

Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Sep 10
Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?

Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Jun 07
Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

May 16
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Mar 17
Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?

Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Jan 29
Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future

Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Dec 14
Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?

Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Oct 12
Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns

Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Aug 27
Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?

Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

Jul 06
Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Surendran Chemmenkotil rispetto agli utili di Metropolis Healthcare?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

₹1b

Jun 30 2024n/an/a

₹1b

Mar 31 2024n/an/a

₹1b

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹52m₹13m

₹1b

Compensazione vs Mercato: Dati insufficienti per stabilire se la retribuzione totale di Surendran sia ragionevole rispetto ad aziende di dimensioni simili nel mercato Indian.

Compensazione vs guadagni: Dati insufficienti per confrontare la retribuzione di Surendran con le performance aziendali.


AMMINISTRATORE DELEGATO

Surendran Chemmenkotil

1.8yrs

Mandato

₹52,318,552

Compensazione

Mr. Surendran Chemmenkotil is Chief Executive Officer of Metropolis Healthcare Limited from January 2, 2023. He is a seasoned leader with rich and diverse experience across consumer facing companies such a...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Ameera Shah
Executive Chairperson16.5yrs₹47.88m0.35%
₹ 374.9m
Sushil Shah
Founder & Chairman Emeritusno data₹18.00m18.44%
₹ 19.5b
Surendran Chemmenkotil
Chief Executive Officer1.8yrs₹52.32mNessun dato
Aditya Shinde
Interim Chief Financial Officerno dataNessun datoNessun dato
Kannan Alangadan
Chief Operating Officerno dataNessun datoNessun dato
Kirti Chadha
Chief Scientific & Innovation Officerno dataNessun datoNessun dato
Pinakin Shah
Chief Information Officerless than a yearNessun datoNessun dato
Kamlesh Kulkarni
Head of Legal & Secretarial and Compliance Officerless than a yearNessun datoNessun dato
Jeyasingh Balakrishnan
Head of Public Relations & Corporate Communications3.2yrsNessun datoNessun dato
Mohan Menon
Chief Marketing Officer1.3yrsNessun datoNessun dato
Ishita Medhekar
Chief People Officer4.8yrsNessun datoNessun dato
Nilesh Shah
President of Internal Assurance & Advisor to CEOno dataNessun datoNessun dato

1.0yrs

Durata media

45yo

Età media

Gestione esperta: Il team dirigenziale di METROPOLIS non è considerato esperto (durata media 1 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Ameera Shah
Executive Chairperson16.5yrs₹47.88m0.35%
₹ 374.9m
Sushil Shah
Founder & Chairman Emeritus19.3yrs₹18.00m18.44%
₹ 19.5b
Anita Ramachandran
Non-Executive Independent Director4.5yrs₹2.18mNessun dato
Sanjay Bhatnagar
Non-Executive Independent Director6.2yrs₹1.73mNessun dato
Vivek Gambhir
Non-Executive Independent Director6.2yrs₹1.85m0.00028%
₹ 296.0k
Ranganathan Subramanian
Independent Directorless than a year₹500.00kNessun dato
Hemant Sachdev
Non-Executive Independent Director3.5yrsNessun datoNessun dato
Aparna Rajadhyaksha
Non-Executive Directorless than a yearNessun datoNessun dato

5.3yrs

Durata media

58.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di METROPOLIS sono considerati esperti (durata media dell'incarico 5.3 anni).